Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Global health

Global pharmacist body wants strategies to boost safe medicine use

Pharmacist and report editor Katri Hameen-Anttila, head of R&D at the Finnish Medicines Agency

Source: Jesse Photography

Katri Hämeen-Anttila, report editor and head of R&D at the Finnish Medicines Agency, says: “Pharmacists’ expertise is highly relevant to guiding the development and implementation of medicines information strategies”

Governments and pharmacy organisations should develop and introduce national medicines information strategies to improve the safe and effective use of medicines across the world, according to a report by global pharmacist body the International Pharmaceutical Federation (FIP). 

Pharmacists also have a role to play in using reliable medicines information sources which would boost adherence and the rational use of medicines, says the federation that incorporates the national pharmacist associations of its 139 member countries as well as academic institutions.

Training on medicines information and how to use it should also be written into health professions’ education and health professionals should also be taught the skills they need to counsel patients about their medication, suggests the report entitled ‘Medicines Information, Strategic Development’, published on 31 January 2017. 

“Pharmacists’ expertise is highly relevant to guiding the development and implementation of medicines information strategies within national medicines and health policies,” comments report editor Katri Hämeen-Anttila, a pharmacist and head of research and development at the Finnish Medicines Agency. 

The report reveals what best practice medicines information looks like and throws the spotlight on the United States, UK and Finland, where strategies already exist. 

It also suggests ways that low-income countries can develop medicines information within their own medicines management policies.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202283

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Pharmacist and report editor Katri Hämeen-Anttila, head of R&D at the Finnish Medicines Agency

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.